Report cover image

Cottonseed Oil Market Share, Size, Trends, Industry Analysis Report, By Product Type (Processed and Virgin); By End User; By Distribution Channel; By Region; Segment Forecast, 2024 – 2032

Published Sep 01, 2025
Length 129 Pages
SKU # PLRS20470448

Description

The global cottonseed oil market size is expected to reach USD 5.50 billion by 2032, according to a new study by Polaris Market Research. The report “Cottonseed Oil Market Share, Size, Trends, Industry Analysis Report, By Product Type (Processed and Virgin); By End User; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Increasing number of consumers shifting towards the healthier and organic alternatives of traditional oil products and surging product popularity as a good source of proteins, vitamins, and minerals that help to tackle numerous diseases including cancer, depression, and asthma, are prominent factors boosting the global market growth. Additionally, cottonseed oil is now finding application in various different industries apart from food like cosmetics, pharmaceuticals, and biodiesel production and several manufacturers are investing heavily in the R&D to innovate new products, which fuels the product demand and growth.

For instance, in April 2023, Cargill, announced the expansion of its crush capacity with a total investment of USD 50 million, to meet the rising demand for Australian canola and cottonseed oil. The investment will help the company to cater the demand from customers for cottonseed and canola products and also provide farmers access to the global markets.

The significant advances in analytical techniques and quality control systems which have allowed for better monitoring and assessment of cottonseed oil quality and development of rapid testing methods for determining various parameters such as fatty acid composition, oxidative stability, and sensory attributes that ensures the consistent quality and meet the regulatory standards set by government authorities, has been creating new growth opportunities for the market.

Several major companies operating in the market are incorporating blockchain and RFID technologies to provide real-time tracking of cottonseed oil from farm to table, while ensuring transparency and quality assurance and are also seeking innovative packaging solutions such as the use of eco-friendly materials and improved barrier properties to preserve the oil's freshness and quality, has been acting as the major emerging trend in the market.

Cottonseed Oil Market Report Highlights

Processed segment accounted for global market share in 2022, which is mainly driven by increased product usage in the preparation of food products like salad dressings and fried foods

Food service segment held the maximum market revenue share in 2022, on account of significant expansion of food service industry and surging number of restaurants and food chains globally

Online segment is projected to grow during the anticipated period, mainly accelerated to rising internet penetration and number of people opting for online shopping channels

The Asia Pacific region dominated the global market with substantial share in 2022, owing to presence of large customer base for food products and favorable climatic conditions for cotton cultivation

The global key market players include Cargill Incorporated, Maharashtra Solvent Extraction, Swarna Industries, Archer Daniels Midland Company, and Adani Wilmar

Polaris Market Research has segmented the cottonseed oil market report based on product type, end user, distribution channel, and region:

Cottonseed Oil, Product Type Outlook (Revenue - USD Billion, 2023 - 2032)

Processed

Virgin

Cottonseed Oil, End User Outlook (Revenue - USD Billion, 2023 - 2032)

Food Service

Processors

Retail

Others

Cottonseed Oil, Distribution Channel Outlook (Revenue - USD Billion, 2023 - 2032)

Modern Trade

Franchise Outlets

Specialty Stores

Online

Others

Cottonseed Oil, Regional Outlook (Revenue - USD Billion, 2023 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

129 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global Gout Therapeutics Market Insights
4.1. Gout Therapeutics Market – Market Snapshot
4.2. Gout Therapeutics Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Rising Prevalence of Gout and Lifestyle Disorders
4.2.1.2. Increased Geriatric Population Base
4.2.2. Restraints and Challenges
4.2.2.1. High cost of advanced therapies and limited reimbursement in emerging markets.
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Gout Therapeutics Market Trends
4.6. Value Chain Analysis
5. Global Gout Therapeutics Market, by Drug Class
5.1. Key Findings
5.2. Introduction
5.2.1. Global Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
5.3. NSAIDs
5.3.1. Global Gout Therapeutics Market, by NSAIDs, by Region, 2020-2034 (USD Billion)
5.4. Corticosteroids
5.4.1. Global Gout Therapeutics Market, by Corticosteroids, by Region, 2020-2034 (USD Billion)
5.5. Colchicine
5.5.1. Global Gout Therapeutics Market, by Colchicine, by Region, 2020-2034 (USD Billion)
5.6. Urate-Lowering Agents
5.6.1. Global Gout Therapeutics Market, by Urate-Lowering Agents, by Region, 2020-2034 (USD Billion)
5.7. Others
5.7.1. Global Gout Therapeutics Market, by Others, by Region, 2020-2034 (USD Billion)
6. Global Gout Therapeutics Market, by Disease Condition
6.1. Key Findings
6.2. Introduction
6.2.1. Global Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
6.3. Acute Gout
6.3.1. Global Gout Therapeutics Market, by Acute Gout, by Region, 2020-2034 (USD Billion)
6.4. Chronic Gout
6.4.1. Global Gout Therapeutics Market, by Chronic Gout, by Region, 2020-2034 (USD Billion)
7. Global Gout Therapeutics Market, by Distribution Channel
7.1. Key Findings
7.2. Introduction
7.2.1. Global Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
7.3. Hospital Pharmacy
7.3.1. Global Gout Therapeutics Market, by Hospital Pharmacy, by Region, 2020-2034 (USD Billion)
7.4. Retail Pharmacy
7.4.1. Global Gout Therapeutics Market, by Retail Pharmacy, by Region, 2020-2034 (USD Billion)
7.5. Online Pharmacy
7.5.1. Global Gout Therapeutics Market, by Online Pharmacy, by Region, 2020-2034 (USD Billion)
8. Global Gout Therapeutics Market, by Geography
8.1. Key Findings
8.2. Introduction
8.2.1. Gout Therapeutics Market Assessment, By Geography, 2020-2034 (USD Billion)
8.3. Gout Therapeutics Market – North America
8.3.1. North America: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.3.2. North America: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.3.3. North America: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.3.4. Gout Therapeutics Market – U.S.
8.3.4.1. U.S.: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.3.4.2. U.S.: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.3.4.3. U.S.: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.3.5. Gout Therapeutics Market – Canada
8.3.5.1. Canada: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.3.5.2. Canada: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.3.5.3. Canada: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.4. Gout Therapeutics Market – Europe
8.4.1. Europe: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.4.2. Europe: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.4.3. Europe: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.4.4. Gout Therapeutics Market – UK
8.4.4.1. UK: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.4.4.2. UK: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.4.4.3. UK: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.4.5. Gout Therapeutics Market – France
8.4.5.1. France: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.4.5.2. France: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.4.5.3. France: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.4.6. Gout Therapeutics Market – Germany
8.4.6.1. Germany: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.4.6.2. Germany: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.4.6.3. Germany: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.4.7. Gout Therapeutics Market – Italy
8.4.7.1. Italy: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.4.7.2. Italy: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.4.7.3. Italy: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.4.8. Gout Therapeutics Market – Spain
8.4.8.1. Spain: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.4.8.2. Spain: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.4.8.3. Spain: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.4.9. Gout Therapeutics Market – Netherlands
8.4.9.1. Netherlands: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.4.9.2. Netherlands: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.4.9.3. Netherlands: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.4.10. Gout Therapeutics Market – Russia
8.4.10.1. Russia: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.4.10.2. Russia: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.4.10.3. Russia: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.4.11. Gout Therapeutics Market – Rest of Europe
8.4.11.1. Rest of Europe: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.4.11.2. Rest of Europe: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.4.11.3. Rest of Europe: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.5. Gout Therapeutics Market – Asia Pacific
8.5.1. Asia Pacific: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.5.2. Asia Pacific: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.5.3. Asia Pacific: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.5.4. Gout Therapeutics Market – China
8.5.4.1. China: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.5.4.2. China: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.5.4.3. China: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.5.5. Gout Therapeutics Market – India
8.5.5.1. India: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.5.5.2. India: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.5.5.3. India: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.5.6. Gout Therapeutics Market – Malaysia
8.5.6.1. Malaysia: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.5.6.2. Malaysia: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.5.6.3. Malaysia: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.5.7. Gout Therapeutics Market – Japan
8.5.7.1. Japan: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.5.7.2. Japan: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.5.7.3. Japan: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.5.8. Gout Therapeutics Market – Indonesia
8.5.8.1. Indonesia: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.5.8.2. Indonesia: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.5.8.3. Indonesia: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.5.9. Gout Therapeutics Market – South Korea
8.5.9.1. South Korea: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.5.9.2. South Korea: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.5.9.3. South Korea: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.5.10. Gout Therapeutics Market – Australia
8.5.10.1. Australia: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.5.10.2. Australia: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.5.10.3. Australia: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.5.11. Gout Therapeutics Market – Rest of Asia Pacific
8.5.11.1. Rest of Asia Pacific: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.5.11.2. Rest of Asia Pacific: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.5.11.3. Rest of Asia Pacific: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.6. Gout Therapeutics Market – Middle East & Africa
8.6.1. Middle East & Africa: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.6.2. Middle East & Africa: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.6.3. Middle East & Africa: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.6.4. Gout Therapeutics Market – Saudi Arabia
8.6.4.1. Saudi Arabia: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.6.4.2. Saudi Arabia: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.6.4.3. Saudi Arabia: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.6.5. Gout Therapeutics Market – UAE
8.6.5.1. UAE: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.6.5.2. UAE: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.6.5.3. UAE: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.6.6. Gout Therapeutics Market – Israel
8.6.6.1. Israel: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.6.6.2. Israel: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.6.6.3. Israel: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.6.7. Gout Therapeutics Market – South Africa
8.6.7.1. South Africa: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.6.7.2. South Africa: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.6.7.3. South Africa: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.6.8. Gout Therapeutics Market – Rest of Middle East & Africa
8.6.8.1. Rest of Middle East & Africa: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.6.8.2. Rest of Middle East & Africa: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.6.8.3. Rest of Middle East & Africa: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.7. Gout Therapeutics Market – Latin America
8.7.1. Latin America: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.7.2. Latin America: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.7.3. Latin America: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.7.4. Gout Therapeutics Market – Mexico
8.7.4.1. Mexico: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.7.4.2. Mexico: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.7.4.3. Mexico: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.7.5. Gout Therapeutics Market – Brazil
8.7.5.1. Brazil: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.7.5.2. Brazil: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.7.5.3. Brazil: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.7.6. Gout Therapeutics Market – Argentina
8.7.6.1. Argentina: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.7.6.2. Argentina: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.7.6.3. Argentina: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
8.7.7. Gout Therapeutics Market – Rest of Latin America
8.7.7.1. Rest of Latin America: Gout Therapeutics Market, by Drug Class, 2020-2034 (USD Billion)
8.7.7.2. Rest of Latin America: Gout Therapeutics Market, by Disease Condition, 2020-2034 (USD Billion)
8.7.7.3. Rest of Latin America: Gout Therapeutics Market, by Distribution Channel, 2020-2034 (USD Billion)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. Arrowhead Pharmaceuticals, Inc.
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. AstraZeneca
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development
10.3. Eisai Co., Ltd.
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. GSK plc.
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. Merck & Co., Inc.
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. Novartis AG
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. Takeda Pharmaceutical Company Limited
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. Teijin Pharma Ltd.
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. Zydus Group
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development
10.10. Regeneron Pharmaceuticals Inc.
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Recent Development
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.